Technology

Latest News


Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.

Finding the Best Path Forward for Adoption of Prescription Digital Therapeutics

CME Content


The Council for Affordable Quality Health Committee on Operating Rules for Information Exchange is making great strides in certifying health plans for implementing electronic information exchange between payers and providers. The good news for providers is that very little is required of them to reap the benefits of these certification efforts.

What we're reading, December 29, 2016: President-elect Donald J. Trump considers privatizing veterans' medical care; a new task force to improve sharing of pregnancy status data; and medical marijuana legalization reduced traffic fatalities.

What we’re reading, December 23, 2016: HHS secretary nominee Rep. Tom Price traded $300,000 in healthcare stocks while sponsoring health-related legislature; an economist and a physician suggest creation of digital health biographies; CMS hopes to incentivize cardiac rehabilitation program participation.

Until there is more data to support the outcomes of using telemedicine, payers will be more cautious about getting into reimbursing for the technology, said Anne Schmidt, MD, associate medical director at Blue Cross and Blue Shield of Alabama.

There are long-standing problems associated with the administration of healthcare, such as racial and ethnic health disparities, and the geographic variation in the quality and quantity of care provided, that are important for the healthcare industry to address

Wen Dombrowski, MD, MBA, Resonate Health LLC, said that it’s important to develop health information technologies because the lack thereof not only impacts the individual living with the condition, but the entire environment and community he or she may live in.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo